Bifogade filer
Significant technical progress in the AcouSome project â two novel patent applications filed
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | HÀlsovÄrd |
| Industri | Bioteknik |
In August 2022, the European Innovation Council (EIC) awarded the AcouSort project AcouSome SEK 26 million to develop groundbreaking technology enabling exosome-based diagnostics. The aim of the project is to develop a low cost acoustofluidic thin film actuated chip for separation of extracellular vesicles from blood. Started in the beginning of 2023, the innovation project has already made significant technical progress resulting in two novel patent applications.
Extracellular vesicles are nanoparticles that enable human cells to communicate vital information with each other. These particles have the potential to open a completely new field within diagnostics, as they are predicted to enable early âstatus reportsâ on organs such as the brain and heart, as well as provide vital information on tumor diseases, infectious diseases, pregnancy, and other health conditions.
Of the SEK 26 million granted by the EIC, SEK 12.2 million goes directly to AcouSort, and the remainder of the funding is distributed to AcouSortâs partners Lund University, DTU, and Day One. The project will run for 36 months and is fully funded by the EU.
âThe AcouSome project is an innovation project with potential to contribute to the creation of a completely new field within diagnostics. One year into the project, I am happy to report that we have made significant technical progress, and that we are well placed to exploit our technological achievements for our acoustofluidics separation modules in general, but also for achieving our ultimate objective of developing a robust and cost-effective solution for extracellular vesicle separation,â says Torsten Freltoft, AcouSortâs CEO.